Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.04
-$0.50 (-2.56%)
Nov 2, 2026, 10:40 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -91.05M | -38.26M |
Depreciation & Amortization | 2.21M | 1.17M |
Stock-Based Compensation | 8.26M | 2.59M |
Other Working Capital | -5.7M | -7.67M |
Other Non-Cash Items | 11.05M | 659K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -6.02M | -7.19M |
Operating Cash Flow | -75.54M | -41.04M |
Capital Expenditures | -334K | -148K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | 69.9M | 34.95M |
Other Investing Acitivies | -246.21M | n/a |
Investing Cash Flow | -176.64M | 34.8M |
Debt Repayment | -70K | -24K |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 291.48M | -143K |
Financial Cash Flow | 292.64M | 484K |
Net Cash Flow | 40.59M | -5.73M |
Free Cash Flow | -75.88M | -41.18M |
Adj. Free Cash Flow | -84.14M | -43.77M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ODTX